Array: Analysts Predict a Bright Future
Solar tracker giant Array got Buy ratings and $11 price targets. Focus on utility-scale and turnaround boosted confidence.
Already have an account? Sign in.
Solar tracker giant Array got Buy ratings and $11 price targets. Focus on utility-scale and turnaround boosted confidence.
Stifel initiates Achieve Life Sciences at Buy with an $18 target, citing a manufacturing, leadership, and capital reset ahead of a 2026 NDA resubmission.
Citi says Moderna’s rally after the INTerpath-001 melanoma win pushed its market value near Regeneron’s despite weaker near-term earnings.
CEO says 50% of revenue now comes from work won since AI rolled out. Margins and cash improved, but traditional work is shrinking.